Sara Pechero-Hijazo
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
ClinBioNGS: A Clinical Bioinformatics Pipeline for Integrated Analysis of Somatic Next-Generation Sequencing Cancer Panels.
Journal: JCO clinical cancer informatics
Published: January 08, 2026
NSCLC brain metastases exhibit reduced HLA-I antigen presentation machinery and immune evasion independent of IFNγ signaling defects.
Journal: Molecular cancer
Published: December 08, 2025
Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.
Journal: Cancer research
Published: November 12, 2025
Targeted KRASG12V Degradation in vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.
Journal: Cancer research
Published: November 12, 2025
Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 27, 2025
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study.
Journal: Translational lung cancer research
Published: November 27, 2024
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Journal: Signal transduction and targeted therapy
Published: September 02, 2024
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
Journal: British journal of cancer
Published: September 15, 2023
A Transcriptomic Approach Outperforms Mutational Analysis to Identify KEAP1/NFE2L2 Pathway Activation in Patients With NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 01, 2023
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.
Journal: Molecular oncology
Published: May 09, 2023
Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities.
Journal: Clinical and translational medicine
Published: April 25, 2023
Glucose deprivation drives LIF-dependent lung cancer.
Journal: Nature metabolism
Published: May 15, 2022
Last Updated: 09/26/2026